BioNTech SE
BioNTech SE is a Healthcare company operating in Biotechnology with a $22.81B market cap.
Most recent earnings call: Q4 FY25 on Mar 10, 2026.
20 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-06-21.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Spoken Alpha tracks BNTX's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 9/10 quarters with 50% positive reaction rate
SamplePeers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for BNTX.
$ curl https://api.spokenalpha.com/v1/companies/BNTXFAQ
Spoken Alpha indexes BNTX's earnings call transcripts at https://spokenalpha.com/companies/BNTX. Each call links to attributed speakers and parsed analyst Q&A. BioNTech SE's own investor relations page is at https://investors.biontech.de/.
BioNTech SE (BNTX) held its most recent earnings call on 2026-03-10, covering fiscal Q4 2025.
BioNTech SE (BNTX) operates in the Healthcare sector (Biotechnology industry).
Consistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 3 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2025 | $1.98 | $1.98 | -0.1% | -2.1% | -3.4% |
| Q4 FY2025 | $2.26 | $2.18 | +3.8% | +5.0% | +5.0% |
| Q3 FY2025 | $2.45 | $2.21 | +10.9% | -4.2% | -2.7% |
| Q2 FY2025 | $2.30 | $2.25 | +2.1% | +1.4% | +2.4% |
| Q1 FY2024 | $2.25 | $2.16 | +4.0% | -5.0% | -2.6% |
| Q4 FY2024 |
| $2.27 |
| $2.11 |
| +7.5% |
| +4.9% |
| +5.6% |
| Q3 FY2024 | $2.36 | $2.25 | +4.8% | +0.2% | +0.6% |
| Q2 FY2024 | $2.54 | $2.32 | +9.5% | -2.9% | -5.3% |
| Q1 FY2023 | $2.62 | $2.38 | +10.0% | +1.9% | +3.3% |
| Q4 FY2023 | $2.12 | $2.19 | -3.2% | -3.6% | -5.5% |